Next Article in Journal
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
Previous Article in Journal
Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma
Article Menu

Export Article

Open AccessReview
Cells 2019, 8(2), 104;

Control of the Antitumor Immune Response by Cancer Metabolism

Bordeaux University, CNRS, UMR 5164, ImmunoConcEpT, 33000 Bordeaux, France
Department of Medical Oncology, Hôpital Saint-André, Bordeaux University Hospital-CHU, 33000 Bordeaux, France
Curematch, Inc., 6440 Lusk Bvld, San Diego, CA 92121, USA
Cellomet, CGFB, 146 Rue léo Saignat, F-33000 Bordeaux, France
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Received: 22 December 2018 / Revised: 25 January 2019 / Accepted: 28 January 2019 / Published: 31 January 2019
(This article belongs to the Section Cell Signaling and Regulated Cell Death)
Full-Text   |   PDF [2230 KB, uploaded 13 February 2019]   |  


The metabolic reprogramming of tumor cells and immune escape are two major hallmarks of cancer cells. The metabolic changes that occur during tumorigenesis, enabling survival and proliferation, are described for both solid and hematological malignancies. Concurrently, tumor cells have deployed mechanisms to escape immune cell recognition and destruction. Additionally, therapeutic blocking of tumor-mediated immunosuppression has proven to have an unprecedented positive impact in clinical oncology. Increased evidence suggests that cancer metabolism not only plays a crucial role in cancer signaling for sustaining tumorigenesis and survival, but also has wider implications in the regulation of antitumor immune signaling through both the release of signaling molecules and the expression of immune membrane ligands. Here, we review these molecular events to highlight the contribution of cancer cell metabolic reprogramming on the shaping of the antitumor immune response. View Full-Text
Keywords: cancer; metabolism; immunity cancer; metabolism; immunity

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Domblides, C.; Lartigue, L.; Faustin, B. Control of the Antitumor Immune Response by Cancer Metabolism. Cells 2019, 8, 104.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cells EISSN 2073-4409 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top